Understanding sex-specific differences in sympathetic blood pressure regulation, such as the role of β-adrenergic vasodilatation in women and its loss after menopause, is crucial for the individualized clinical management of hypertension.
No takes yet. Share an insight, caveat, or question.
May inform sex-specific hypertension strategies; leaves open prospective trials on β-adrenergic targeting post-menopause.
Briant et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: